Page last updated: 2024-08-26

cobalt and 12-o-retinoylphorbol-13-acetate

cobalt has been researched along with 12-o-retinoylphorbol-13-acetate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biswas, S; Kumar, N; Nayak, PG; Rao, CM; Reddy, ND; Shoja, MH	1

Other Studies

1 other study(ies) available for cobalt and 12-o-retinoylphorbol-13-acetate

Article	Year
An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells. Chemico-biological interactions, 2016, Jun-25, Volume: 253 Topics: A549 Cells; Acetylation; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cobalt; Cyclin-Dependent Kinase Inhibitor p21; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Phorbol Esters; Poly(ADP-ribose) Polymerases; Sulfonamides; Tubulin; Tumor Suppressor Protein p53	2016

Article

Year

An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells.

Chemico-biological interactions, 2016, Jun-25, Volume: 253

Topics: A549 Cells; Acetylation; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cobalt; Cyclin-Dependent Kinase Inhibitor p21; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; Phorbol Esters; Poly(ADP-ribose) Polymerases; Sulfonamides; Tubulin; Tumor Suppressor Protein p53

2016